AKT1 and neoplasm: observed enhanced expression of PRC2 complex, PI3K/AKT and NOTCH pathway genes, and PI3K/AKT pharmacological inhibition delayed tumour growth and NE transformation in EGFR‐mutant patient‐derived xenografts.